Related Experiment Videos
The murine antibody response to lactate dehydrogenase-elevating virus
The Journal of General Virology
|June 1, 1986
Summary
Mice infected with lactate dehydrogenase-elevating virus (LDV) produce long-lasting IgG antibodies, primarily targeting the viral envelope protein VP3. This T-dependent immune response shows a notable bias towards IgG2a subclass antibodies.
Area of Science:
- Immunology
- Virology
Background:
- Lactate dehydrogenase-elevating virus (LDV) infection in mice elicits a robust antibody response.
- Understanding the specific antibody subclasses and viral targets is crucial for characterizing the immune response to LDV.
Purpose of the Study:
- To investigate the characteristics of the IgG antibody response to LDV infection in mice.
- To identify the specific viral proteins recognized by anti-LDV antibodies.
Main Methods:
- Mice were infected with LDV, and serum antibody titers were measured over time.
- Antibody subclass analysis (IgG1, IgG2a, IgG2b, IgG3) was performed.
- Western blot analysis was used to determine antibody reactivity against viral proteins (VP1, VP2, VP3).
- Hybridoma analysis was conducted to characterize antibody specificities.
Main Results:
- High titers of IgG anti-LDV antibodies persisted for over a year post-infection.
- The antibody response was T-dependent and showed a strong preference for IgG2a, with variable amounts of IgG2b and IgG3, and minimal IgG1.
- Antibodies predominantly reacted with VP3, the glycosylated envelope protein, and to a lesser extent with VP1, the nucleocapsid protein.
- No antibodies against VP2, a non-glycosylated envelope protein, were detected.
- Hybridoma analysis confirmed a preponderance of anti-VP3 specificities.
- VP3 appears to possess a common polypeptide moiety with at least two major epitopes.
Conclusions:
- LDV infection induces a long-lasting, T-dependent IgG antibody response with a distinct subclass profile (IgG2a-dominant).
- The primary target of the humoral immune response is the VP3 protein of the viral envelope.
- VP3's antigenic structure includes a conserved polypeptide core with major epitopes, making it a key target for neutralizing antibodies.